Waters Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Baxter International (BAX) and Waters (WAT)
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Waters (WAT) and Bristol-Myers Squibb (BMY)
Waters Corporation: Cautious Hold Amidst China Headwinds and Mixed Outlook
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Qiagen (QGEN) and Waters (WAT)
BofA Securities Raises Price Target on Waters to $328 From $300, Maintains Neutral Rating
Waters Analyst Ratings
Waters Analyst Ratings
BofA Securities Adjusts Price Target on Waters to $300 From $265, Maintains Neutral Rating
Waters Analyst Ratings
Waters Corporation Downgraded at Barclays Citing Industry Headwinds
Barclays Downgrades Waters to Underweight, Lowers Price Target to $230
Waters Analyst Ratings
JP Morgan Maintains Neutral on Waters, Lowers Price Target to $250
Waters Analyst Ratings
Deutsche Bank Adjusts Waters Price Target to $260 From $295, Maintains Hold Rating
Waters Analyst Ratings
Analysts Offer Insights on Industrial Goods Companies: Seanergy Maritime (SHIP), Continental Aktiengesellschaft (OtherCTTAF) and Waters (WAT)
BofA Securities Adjusts Price Target on Waters to $285 From $305, Maintains Buy Rating
No Data